1937
DOI: 10.1021/ja01281a002
|View full text |Cite
|
Sign up to set email alerts
|

Cinchona Alkaloids in Pneumonia. IV. Derivatives of Ethylapocupreine1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

1940
1940
2005
2005

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Bis(pyrrolo [3,4-d])tetrathiafulvalene [43] (4; Scheme 1), 2-(2-iododethoxy)-ethyl-p-toluenesulfonate [44] (5; Scheme 1), 4-[bis(4-tert-butylphenyl)(4-ethylphenyl)methyl]phenol [21] (9; Scheme 1), compound [28d] 12 (Scheme 1), the chloride [21] 17 (Scheme 2 and 4), 1,1''-[1,4-phenylenebis(methylene)]bis(4,4'-bipyridin-1-ium) bis-(hexafluorophosphate) [45] (16·2 PF 6 ) (Schemes 3 and 5), the iodide [28h] 18 (Scheme 4), 4,5-bis(2-cyanoethylthio)-1,3-dithiole-2-thione [46] (19; Scheme 4), 5-tosyl-(1,3)-dithiolo-[4,5-c]pyrrole-2-one [43] (21; Scheme 4), and 2-(2-chloroethoxy)-ethyl-p-toluenesulfonate [47] (25; Scheme 4) were all prepared according to literature procedures. Solvents were dried according to literature procedures.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Bis(pyrrolo [3,4-d])tetrathiafulvalene [43] (4; Scheme 1), 2-(2-iododethoxy)-ethyl-p-toluenesulfonate [44] (5; Scheme 1), 4-[bis(4-tert-butylphenyl)(4-ethylphenyl)methyl]phenol [21] (9; Scheme 1), compound [28d] 12 (Scheme 1), the chloride [21] 17 (Scheme 2 and 4), 1,1''-[1,4-phenylenebis(methylene)]bis(4,4'-bipyridin-1-ium) bis-(hexafluorophosphate) [45] (16·2 PF 6 ) (Schemes 3 and 5), the iodide [28h] 18 (Scheme 4), 4,5-bis(2-cyanoethylthio)-1,3-dithiole-2-thione [46] (19; Scheme 4), 5-tosyl-(1,3)-dithiolo-[4,5-c]pyrrole-2-one [43] (21; Scheme 4), and 2-(2-chloroethoxy)-ethyl-p-toluenesulfonate [47] (25; Scheme 4) were all prepared according to literature procedures. Solvents were dried according to literature procedures.…”
Section: Methodsmentioning
confidence: 99%
“…The tosyl protecting group on the MPTTF unit was removed in good yield (87 %) using NaOMe in a THF/MeOH mixture. The resultant pyrrole nitrogen atom in 24 was alkylated with compound 25, [47] affording the chloride 26 in 75 % yield. The chloride in compound 26 was initially converted to (26!27) an iodide in 99 % yield and then to (27!28) a thiocyanate group in 99 % yield.…”
Section: Rbpttfmentioning
confidence: 99%
“…Methylapocupreine (isoquinine) is more effective than quinine or dihydroquinine (39,89; also unpublished work); ethylapocupreine has about the same antipneumococcic action as optochin (13, 80, 89). The apocupreine (apoquinine) ethers have lower toxicity than the corresponding ethers of the hydrocupreine or cupreine series, as is apparent in the data cited by Maclachlan (56, 72, 73), Butler (10,13), and Gundel and Seitz (39). Conversion of the vinyl group to an ethylidene group introduces the possibility of geometric isomerism.…”
Section: Variations In the Quinuclidine Nucleusmentioning
confidence: 93%
“…The product, called apoquinine by Hesse (49), consists of substances of different toxicities and antipneumococcic powers and these give derivatives of various biological properties. The name isoquinine (39)] and ethylapocupreine1 or [ethylapoquinine (13,14,22,45,52,56,72,73,76,79,80,81,89,90)] were reported by investigators in the United States, Germany, and Japan to have protective action in experimental pneumonias. Since 1934 Maclachlan et al have published results of the experimental testing of alkyl and hydroxylated alkyl ethers of apocupreine in lower animals and of the use of hydroxyethylapocupreine in the treatment of pneumonia in man.…”
mentioning
confidence: 99%
See 1 more Smart Citation